Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical Practice
Dianalee McKnight1, Ana Morales1, Kathryn E Hatchell1
1Invitae, San Francisco, California.
Genetic testing for epilepsy significantly impacts clinical management, with nearly half of patients experiencing changes in treatment. This genetic diagnosis often leads to positive patient outcomes, including seizure reduction.
Area of Science:
- Genetics
- Neurology
Background:
- Epilepsy diagnosis and management can be complex.
- The impact of genetic diagnoses on epilepsy patient care is not well understood.
Purpose of the Study:
- To evaluate the association between genetic diagnoses in epilepsy patients and subsequent clinical management and outcomes.
Main Methods:
- Retrospective cross-sectional study of 418 epilepsy patients undergoing multigene panel testing.
- Analysis of clinical management changes and patient outcomes reported by healthcare professionals.
Main Results:
- Nearly half of patients (49.8%) with a genetic diagnosis experienced clinical management changes, often within 3 months.
- Positive outcomes were reported in 74.9% of patients with available follow-up, including seizure reduction (64.7%).
- Medication adjustments and specialist referrals were common management changes.
Conclusions:
- Genetic testing in epilepsy patients is associated with significant clinical decision-making.
- Genetic diagnoses can lead to improved patient outcomes and tailored management strategies.
More Related Videos
10:46Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
Published on: September 1, 2023
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Electroconvulsive Therapy
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
